Abstract
Morphine, codeine, normorphine, norcodeine, nalorphine, methadone, pentazocine, cyclazocine, meperidine and levallorphan were tested in vitro for activity as inhibitors of rat brain monoamine oxidase. Beta-phenylisopropylhydrazine and chlorpromazine were used, respectively, as strong and weak inhibitors to define the upper and lower limits of inhibitory activity. All test compounds, with the exception of methadone, were found to be weaker monoamine oxidase inhibitors than chlorpromazine. The log dose-response curve for methadone stretches across four orders of magnitude in concentration and, at low molar concentrations, the monoamine oxidase inhibitory activity of methadone is equivalent to the monoamine oxidase inhibitory activity of betaphenylisopropylhydrazine at equally low concentrations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
